STADA Arzneimittel AG has been managed by Peter Goldschmidt as Chairman of the Executive Board since September 1, 2018. Mark Keatley has been the Chief Financial Officer since September 27, 2017. Miguel Pagan Fernandez has been the Chief Production and Development Officer since July 1, 2018.
We make our press photos available to you at no charge for editorial reporting about the STADA Group. When the photos are used, a copyright notice referring to STADA Arzneimittel AG must be attached. The photos may not be altered and commercial dissemination to third parties is prohibited.